About: Regional chemotherapy in patients with breast carcinoma liver metastases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Regional chemotherapy in patients with breast carcinoma liver metastases Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Background/Aims: Although liver is a common site of metastases in breast cancer, isolated liver metastases in patients with disseminated breast cancer are rare. The role of liver-directed therapies in these patients is based on data derived from retrospective analysis of case series. Methodology: We have reviewed the records of 8 patients with liver metastases and a history of breast cancer treated at our institution over a period of 11 years with regional chemotherapy administered through surgically implanted port systems. Results: Three of the patients also had a history of second primary colorectal carcinoma. One patient had evidence of extrahepatic spread. All patients were treated by regimens based on the combination of 5-fluorouracil and folinic acid. Three patients were also treated by cytoreductive procedures. The median survival times from the diagnosis and port systems implantation were 34 months and 31 months, respectively. Conclusions: Our data support the use of regional intraarterial che Background/Aims: Although liver is a common site of metastases in breast cancer, isolated liver metastases in patients with disseminated breast cancer are rare. The role of liver-directed therapies in these patients is based on data derived from retrospective analysis of case series. Methodology: We have reviewed the records of 8 patients with liver metastases and a history of breast cancer treated at our institution over a period of 11 years with regional chemotherapy administered through surgically implanted port systems. Results: Three of the patients also had a history of second primary colorectal carcinoma. One patient had evidence of extrahepatic spread. All patients were treated by regimens based on the combination of 5-fluorouracil and folinic acid. Three patients were also treated by cytoreductive procedures. The median survival times from the diagnosis and port systems implantation were 34 months and 31 months, respectively. Conclusions: Our data support the use of regional intraarterial che (en) Autoři popisují regionální chemoterapii u pacientů s jaterními metástazemi karcinomu prsu (cs)
Title	Regional chemotherapy in patients with breast carcinoma liver metastases Regionální chemoterapie u pacientů s jaterními metastázemi karcinomu prsu (cs) Regional chemotherapy in patients with breast carcinoma liver metastases (en)
skos:prefLabel	Regional chemotherapy in patients with breast carcinoma liver metastases Regionální chemoterapie u pacientů s jaterními metastázemi karcinomu prsu (cs) Regional chemotherapy in patients with breast carcinoma liver metastases (en)
skos:notation	RIV/00216208:11120/06:00001253!RIV09-MZ0-11120___
http://linked.open...avai/riv/aktivita	Z
http://linked.open...avai/riv/aktivity	Z(MZ0FNHK2005)
http://linked.open...iv/cisloPeriodika	67
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Vobořil, René
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Karlova v Praze / 3. lékařská fakulta
http://linked.open...dnocenehoVysledku	496874
http://linked.open...ai/riv/idVysledku	RIV/00216208:11120/06:00001253
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	breast cancer; hepatic arterial chemotherapy; liver metastases (en)
http://linked.open.../riv/klicoveSlovo	hepatic arterial chemotherapy liver metastases breast cancer
http://linked.open...odStatuVydavatele	DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV	[4D68746D2E8F]
http://linked.open...i/riv/nazevZdroje	Hepato-Gastroenterology
http://linked.open...in/vavai/riv/obor	FJ
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	7 (xsd:int)
http://linked.open...UplatneniVysledku	2006
http://linked.open...v/svazekPeriodika	83
http://linked.open...iv/tvurceVysledku	Cerman, J. Melichar, B. Vobořil, René Mergancová, J. Jandík, P. Melicharová, K. Vobořil, Z.
http://linked.open...ain/vavai/riv/wos	000235485000020
http://linked.open...n/vavai/riv/zamer	Nové diagnostické indikátory a léčebné postupy v závislosti na různých obdobích života s důrazem na stáří
issn	0172-6390
number of pages	6 (xsd:int)
http://localhost/t...ganizacniJednotka	11120

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software